Literature DB >> 7727635

Bacille Calmette-Guérin vaccines: a rough guide.

P E Fine1.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7727635     DOI： 10.1093/clinids/20.1.11

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  14 in total

1.  "To BCG or not to BCG, that is the question!". The challenge of BCG vaccination: Why can't we get it right?

Authors:  Wendy Vaudry
Journal:  Paediatr Child Health       Date:  2003-03       Impact factor: 2.253

Review 2.  Genetic vaccination against tuberculosis.

Authors:  D B Lowrie; C L Silva; R E Tascon
Journal:  Springer Semin Immunopathol       Date:  1997

3.  BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies.

Authors:  Beatriz E Marciano; Chiung-Yu Huang; Gyan Joshi; Nima Rezaei; Beatriz Costa Carvalho; Zoe Allwood; Aydan Ikinciogullari; Shereen M Reda; Andrew Gennery; Vojtech Thon; Francisco Espinosa-Rosales; Waleed Al-Herz; Oscar Porras; Anna Shcherbina; Anna Szaflarska; Şebnem Kiliç; Jose L Franco; Andrea C Gómez Raccio; Persio Roxo; Isabel Esteves; Nermeen Galal; Anete Sevciovic Grumach; Salem Al-Tamemi; Alisan Yildiran; Julio C Orellana; Masafumi Yamada; Tomohiro Morio; Diana Liberatore; Yoshitoshi Ohtsuka; Yu-Lung Lau; Ryuta Nishikomori; Carlos Torres-Lozano; Juliana T L Mazzucchelli; Maria M S Vilela; Fabiola S Tavares; Luciana Cunha; Jorge A Pinto; Sara E Espinosa-Padilla; Leticia Hernandez-Nieto; Reem A Elfeky; Tadashi Ariga; Heike Toshio; Figen Dogu; Funda Cipe; Renata Formankova; M Enriqueta Nuñez-Nuñez; Liliana Bezrodnik; Jose Gonçalo Marques; María I Pereira; Viviana Listello; Mary A Slatter; Zohreh Nademi; Danuta Kowalczyk; Thomas A Fleisher; Graham Davies; Bénédicte Neven; Sergio D Rosenzweig
Journal:  J Allergy Clin Immunol       Date:  2014-04       Impact factor: 10.793

4.  A point mutation in the mma3 gene is responsible for impaired methoxymycolic acid production in Mycobacterium bovis BCG strains obtained after 1927.

Authors:  M A Behr; B G Schroeder; J N Brinkman; R A Slayden; C E Barry
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

5.  Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis.

Authors:  Hans Joachim Mollenkopf; Leander Grode; Jens Mattow; Maik Stein; Peggy Mann; Bernhard Knapp; Jeffrey Ulmer; Stefan H E Kaufmann
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

6.  Impact of methoxymycolic acid production by Mycobacterium bovis BCG vaccines.

Authors:  Adam Belley; David Alexander; Tania Di Pietrantonio; Manon Girard; Joses Jones; Erwin Schurr; Jun Liu; David R Sherman; Marcel A Behr
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

Review 7.  Evolution of M. bovis BCG Vaccine: Is Niacin Production Still a Valid Biomarker?

Authors:  Sarman Singh; Manoj Kumar; Pragati Singh
Journal:  Tuberc Res Treat       Date:  2015-01-28

8.  Factors associated with tuberculosis infection, and with anti-mycobacterial immune responses, among five year olds BCG-immunised at birth in Entebbe, Uganda.

Authors:  Swaib Abubaker Lule; Patrice A Mawa; Gyaviira Nkurunungi; Margaret Nampijja; Dennison Kizito; Florence Akello; Lawrence Muhangi; Alison M Elliott; Emily L Webb
Journal:  Vaccine       Date:  2014-12-19       Impact factor: 3.641

9.  Effectiveness of the First Dose of BCG against Tuberculosis among HIV-Infected, Predominantly Immunodeficient Children.

Authors:  Joaquim C V D Van-Dunem; Laura C Rodrigues; Luiz Claudio Arraes Alencar; Maria de Fátima Pessoa Militão-Albuquerque; Ricardo Arraes de Alencar Ximenes
Journal:  Biomed Res Int       Date:  2015-06-29       Impact factor: 3.411

10.  A Mycobacterium bovis BCG-naked DNA prime-boost vaccination strategy induced CD4⁺ and CD8⁺ T-cell response against Mycobacterium tuberculosis immunogens.

Authors:  Miao Lu; Zhi Yang Xia; Lang Bao
Journal:  J Immunol Res       Date:  2014-03-11       Impact factor: 4.818
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.